Clinical Trials Logo

Filter by:
NCT ID: NCT05139680 Completed - Clinical trials for Hereditary Transthyretin Amyloidosis (ATTRv) Cardiomyopathy (CM), Mixed Phenotype

This Study Will Examine the Clinical Effectiveness of Tafamidis in Patients With Mixed Phenotype Hereditary Transthyretin Amyloidosis

Start date: March 8, 2023
Phase:
Study type: Observational

This study will examine the clinical effectiveness of Tafamidis in patients with Mixed Phenotype Hereditary Transthyretin Amyloidosis using data that already exist in patients' medical records.

NCT ID: NCT05139472 Completed - Diabetes Mellitus Clinical Trials

Impact of Empagliflozin on Functional Capacity in Heart Failure With Preserved Ejection Fraction

Start date: November 9, 2021
Phase: Phase 3
Study type: Interventional

Sodium-Glucose Cotransporter-2 (SGLT-2) inhibitors generally and empagliflozin specifically have shown cardiovascular benefits in patients with heart failure (HF), but the underlying mechanisms remain unclear. Empagliflozin use resulted in lower pulmonary artery diastolic pressures in patients with HF, suggesting a beneficial diuretic effect. Other potential mechanisms include increased blood volume, decreased blood pressure, and changes in sympathetic and neuro-hormonal activation. This study is a single-arm, open label, prospective interventional study of 8 subjects with heart failure with preserved ejection fraction (HFpEF). Before and after 12 weeks of daily empagliflozin, participants with undergo comprehensive invasive exercise testing with a right heart catheter. Our goal is to evaluate the effects of empagliflozin on fitness, assessed by peak VO2, and peak left ventricular filling pressure, assessed by pulmonary capillary pressure at peak exercise.

NCT ID: NCT05139459 Completed - Sepsis Clinical Trials

Sepsis Characterization in Kilimanjaro

SICK
Start date: January 17, 2022
Phase:
Study type: Observational

The aim of this study is to prospectively evaluate the barriers to care, evaluation, clinical practices, and outcomes for patients presenting with sepsis to hospitals in the Kilimanjaro Region of northern Tanzania. This will include an assessment of timing and selection of antimicrobials and administration and volume of intravenous fluids. The study also aims to characterize sepsis sub-types in the epidemiologic context of northern Tanzania using statistical clustering techniques of clinical variables and of host immune response patterns.

NCT ID: NCT05139303 Completed - Clinical trials for Obstructive Sleep Apnea

Efficacy of the OrthoApnea NOA® Mandibular Advancement Device in the Management of Obstructive Sleep Apnea.

Start date: November 15, 2021
Phase: N/A
Study type: Interventional

The objective of this study is to assess the efficacy of the Orthoapnea NOA® mandibular advancement device and describe the percentage of advancement (%) needed to reach efficacy, and to retrospectively compare with other MAD designs in the management of obstructive sleep apnea. Additionally, to describe patient compliance and adherence to the therapy with the Orthoapnea NOA® device, and to assess the incidence and prevalence of signs, symptoms, and diagnosis of temporomandibular disorders (TMD) associated to the use of the Orthoapnea NOA® mandibular advancement device.

NCT ID: NCT05139264 Completed - Clinical trials for Metabolism Disorder, Glucose

Glucose, Activity, Diet, & Sleep Assessment Study

GLADS
Start date: May 3, 2021
Phase:
Study type: Observational

GLADS is a cross-sectional, observational study assessing free-living diet, physical activity, sleep, and glucose profile over a 2-week period in healthy adult men and women.

NCT ID: NCT05139251 Completed - Positive Parenting Clinical Trials

Positive Parenting: Empowering Young Mothers Experiencing Homelessness With a History of Inter-personal Violence to Improve Parenting Strategies

Start date: September 7, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to strengthen the skills and self-efficacy of women by addressing the social and emotional trauma that they have experienced from inter-personal violence (IPRV) and homelessness and to promote positive parenting strategies through Play and Learning Strategies (ePALS), an evidence based intervention.

NCT ID: NCT05139030 Completed - Knee Osteoarthritis Clinical Trials

Phase 3 Adductor Canal Block With EXPAREL in Subjects Undergoing Primary Unilateral Total Knee Arthroplasty

Start date: January 18, 2022
Phase: Phase 3
Study type: Interventional

The purpose of the study is to compare magnitude of postsurgical analgesic effect in different groups following a single dose of study drug when administered via adductor canal block in subjects undergoing primary unilateral total knee arthroplasty.

NCT ID: NCT05138939 Completed - Clinical trials for Vascular Function; Platelet Aggregation

Effects of Japanese Red Wines on Vascular Function in Adult Men

Start date: November 17, 2021
Phase: N/A
Study type: Interventional

The overall objective of this study is to investigate the effects of different types of red wine on markers of endothelial function and platelet aggregation.

NCT ID: NCT05138874 Completed - Clinical trials for Acute Respiratory Infection

Improving Safe Antibiotic Prescribing in Telehealth

Start date: March 3, 2022
Phase: N/A
Study type: Interventional

Appropriate use of antibiotics reduces resistance and protects patients from unnecessary harm. Important advances in antibiotic stewardship have been achieved in outpatient settings, but little is known about stewardship in the rapidly growing telehealth sector. Prior pragmatic randomized trials have shown that Centers for Disease Control (CDC) Core Element interventions constructed using insights from decision and social psychology can greatly reduce inappropriate prescribing in outpatient settings. In a randomized trial, the investigators will adapt and test two aspects of CDC Core Elements in a telehealth environment (Teladoc®), each with two levels of intensity. Teladoc® clinicians will be randomized to the following interventions: 1) Performance Feedback (Trending, Benchmark Peer Comparison), 2) Commitment (Private, Public), or 3) Control. All randomization occurs at the provider level, with the exception of the Public Commitment arm, which requires patient-facing content that is determined by patient state. Clinicians and members will see the same messages across all pages, all channels & all consults during the 12-month study period. The primary outcome is to assess change in antibiotic prescribing rate for qualifying acute respiratory infection visits (ARIs).

NCT ID: NCT05138809 Completed - Physically Disabled Clinical Trials

Evaluation of the Lakeshore Online Fitness Program

Start date: September 22, 2021
Phase: N/A
Study type: Interventional

The purpose of this project is to test feasibility of an online platform that delivers virtual exercise programs for individuals with physical disabilities.